Cristiano Ronaldo has acquired a 10% stake in Herbalife's HBL Pro2col subsidiary for $7.5 million (€6.4 million), boosting the company's stock by over 15% as of Thursday morning. This investment marks a significant milestone in Ronaldo's decade-long partnership with Herbalife, demonstrating his confidence in the company's personalized nutrition and wellness platform, Pro2col.
Pro2col is a next-generation digital health and wellness operating system that uses AI and data-driven insights to deliver personalized nutrition plans. The platform is designed to drive daily engagement, sustainable behavior change, and measurable outcomes. Ronaldo's investment underscores his commitment to health and nutrition, aligning with Herbalife's ambition to make data-driven wellness accessible globally.
Ronaldo, who has been a paid Herbalife ambassador since 2013, sees this investment as a natural evolution of their partnership. Herbalife's CEO, Stephan Gratziani, welcomes Ronaldo's investment, highlighting their shared vision for personalized health and wellness.
Pro2col is a next-generation digital health and wellness operating system that uses AI and data-driven insights to deliver personalized nutrition plans. The platform is designed to drive daily engagement, sustainable behavior change, and measurable outcomes. Ronaldo's investment underscores his commitment to health and nutrition, aligning with Herbalife's ambition to make data-driven wellness accessible globally.
Ronaldo, who has been a paid Herbalife ambassador since 2013, sees this investment as a natural evolution of their partnership. Herbalife's CEO, Stephan Gratziani, welcomes Ronaldo's investment, highlighting their shared vision for personalized health and wellness.
